Clinical Trials of Idiotype‐Specific Vaccine in B‐Cell Lymphomas

Annals of the New York Academy of Sciences

Volumn 690, Issue 1, 1993, Pages 385-387

  HSU, F J ^a   KWAK, L ^a   CAMPBELL, M ^a   LILES, T ^a   CZERWINSKI, D ^a   HART, S ^a   SYRENGELAS, A ^a   MILLER, R ^a   LEVY, R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CELL SURFACE IMMUNOGLOBULIN; TUMOR ANTIGEN; TUMOR CELL VACCINE;

ADULT; ARTHRALGIA; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MYALGIA; PRIORITY JOURNAL; SKIN MANIFESTATION; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMAN; IMMUNOGLOBULIN IDIOTYPES; IMMUNOTHERAPY, ACTIVE; LYMPHOMA, B-CELL; MALE; MIDDLE AGE;

EID: 0027296344     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1993.tb44039.x     Document Type: Article

References (5)